Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Notice of Results

1 Mar 2017 07:00

RNS Number : 1184Y
NMC Health Plc
01 March 2017
 

NMC Health plc to Report Full Year 2016 Results on 8 March 2017

 

London, 1 March 2017: NMC Health plc (the "Company") will report its full year 2016 financial results (for the twelve months to 31 December 2016) on Wednesday, 8 March 2017.

 

The results are expected to be published on the Regulatory News Service at 7am UK time on that day, and shortly thereafter on the Company's website at http://www.nmchealth.com/investor-relations/.

 

Dial-in details for a conference call for analysts and investors will be circulated in due course.

 

Contacts

 

NMC

Prasanth Manghat, Deputy Chief Executive Officer

+971 (0)50 522 5648

Suresh Krishnamoorthy, Chief Financial Officer

+971 (0)50 591 5365

Roy Cherry, Head of Strategy & Investor Relations

+971 (0)50 667 0184

 

Media

FTI Consulting, London

Matthew Cole

+44 (0)20 3727 1101

 

FTI Consulting, Gulf

Shane Dolan

+971 (0)4 437 2100

 

About NMC Health

The Group is the leading private sector healthcare operator in the United Arab Emirates, with a nation-wide network of hospitals and operations in the country since 1975. The Group currently operates or manages eight hospitals, two day-care patient centres, nine medical centres and fifteen pharmacies. In addition, the Group owns and operates Clinica Eugin in Barcelona, Spain - one of the leading fertility treatment centres globally. NMC also owns 51 per cent. shareholding in Fakih IVF Group, the Middle East market leader for in-vitro fertilisation ("IVF") services. Moreover, NMC also owns and operates Americare Group, the leading home care provider in the UAE as well as ProVita, the pioneering provider of long-term medical care, also in the UAE. The enlarged company received almost 3.2 million patients in 2015. The Group is also a leading UAE supplier of products and consumables across several key market segments, with the major contribution coming from healthcare related products. The Group reported revenues of US$880.9 million for the year ended 31 December 2015.

 

In April 2012 NMC was listed on the Premium Segment of the London Stock Exchange. NMC is a constituent of the FTSE 250 Index.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NORUWRBRBSAUUAR

Related Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Back to RNS